BrainStorm Cell raises $10.5M in a private placement BrainStorm announced that it has entered into definitive agreements with a group of investors, including several healthcare-focused funds, in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, BrainStorm will receive gross proceeds of $10.5M, resulting from the issuance and sale of 42M shares of common stock at a price per share of 25c. Maxim Group LLC acted as sole placement agent for the financing.
Piper Jaffray and the Alliance for Regenerative Medicine co-host conference 3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link